Roche gets breakthrough status for Alzheimer's test Elecsys
July 20, 2018 at 01:31 AM EDT
The U.S. Food and Drug Administration has granted Roche an accelerated review for its Elecsys product used to diagnose Alzheimer's disease, the Swiss drugmaker said on Friday.
